Excited to share my lab’s new paper out today Cell. "Touch neurons underlying dopaminergic pleasurable touch and sexual receptivity" Congratulations to this amazing team of scientists. cell.com/cell/fulltext/…

.@EmmaKurz from Dafna Bar-Sagi’s laboratory @NYUGrossman talked about her research on the connection between anti-tumor activity and aerobic exercise, to find a way to mimic these effects >>> 4/7 biotechniques.com/cancer-researc… #IWD2023 #WomenInSTEM #IWD #February11

Neutrophils leaving the marrow after myeloid growth factor

#OpenAccess in @nature: Microbiota-derived 3-IAA influences chemotherapy efficacy in #PancreaticCancer nature.com/articles/s4158… “microbiota-derived tryptophan metabolite indole-3-acetic acid (3-IAA) is enriched in pancreatic cancer patients who respond to treatment”

Given extensive evidence implicating the gut microbiome in oncogenesis of pancreatic cancer (& our work w MD Anderson Cancer Center NYU Grossman School of Medicine showing exercise modulates PDA), a new study from Penn Medicine provides further justification to begin to connect these emerging observations

Coolest study of the year in ⁦Science Magazine⁩ uses our mammalian counterparts to address a major clinical issue: immobilized patients rapidly thrombose, yet hibernating bears remain clot-free all winter (use HSP w/ vast therapeutic implications🐻)! science.org/doi/10.1126/sc…

~32,000 patients are diagnosed with cancer of unknown primary (CUP) every year, the prognosis is often poor… if identified instead w/ a new #machinelearning classifier, patients with CUP could be more likely to receive appropriately targeted therapies and have better outcomes.

Well, 9 years later and here we are! My name is Emma S. Kurz and I’m an MS4 at NYU Grossman School of Medicine & PhD at NYU MSTP, applying to categorical #InternalMedicine and #PSTP programs for #Match2024! Dedicated to tumor immunology, all pups, & education reform…I’m very excited to meet you!

🆕 Science Immunology Contrary to science dogma, the programmed cell death (PD-1) receptor on immune cells exists as a dimer (not just as a monomer). Its stimulation (checkpoint agonist) may be well suited to treat/prevent autoimmune diseases science.org/doi/10.1126/sc… Elliot Philips

Still can’t believe it’s real. Matched at MassGeneral Medicine for Internal Medicine in the Stanbury Physician Scientist Track!! So beyond grateful to everyone who got me here, it only took a decade 🥹🥹 MGH IM Residents #Match2024 #MatchDay2024

An #OpenAccess commentary on the Crosstalk between Exercise and Immunotherapy spj.science.org/doi/10.34133/r… Leads off with data from Dafna Bar-Sagi Emma S. Kurz, MD PhD paper in #PancreaticCancer cell.com/cancer-cell/fu…

#OpenAccess in Cancer Immunology Research Blockade of IL-1β and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic #PancreaticCancer with heterogeneous effects in the tumor aacrjournals.org/cancerimmunolr… A phase 1 trial (co-led by Hale Family Center For Pancreatic Cancer Research & NYU Langone Health) with

We’ve known exercise improves human health for decades, but how? In nature brilliant Gemma Conroy summarizes cellular level mechanisms (secretome, EVs, myokines, systemic immunity etc)… honored to have our work exploring a therapeutic role for exercise in pancreatic cancer via

Excited to share my recently published perspective in NEJM on the clinical implications of DESTINY-Breast06 Which patients with HR+ metastatic #breastcancer should receive T-DXd first-line after endocrine tx and CDK4/6i? How are we thinking about HER2-ultralow disease? Read

#mRNAvaccines for #PancreaticCancer (PDAC) PART4 1. Out today in nature nature.com/articles/s4158… 🧵👇🏽 [1/23]

Funny how two of the more interesting pieces of data at #ASCO25 have little to do with extraneous medications per se, but rather the body’s circadian rhythm and physiology: 1: Exercise after surgery 2: Checkpoint inhibitors in the morning